» Articles » PMID: 15722651

Control of Blood Pressure and Other Cardiovascular Risk Factors at Different Practice Settings: Outcomes of Care Provided to Diabetic Women Compared to Men

Abstract

Cardiovascular disease (CVD) is the major cause of morbidity and mortality in diabetes. To determine the proportion of patients who met the American Diabetes Association guidelines for control of CVD risk factors and to assess the achievement of these guidelines in women compared with men, we conducted a cross-sectional study of 3678 diabetic cohorts followed at seven medical centers, two Veteran Administration hospitals, three urban clinics, and two suburban clinics. Overall, 28% met the target blood pressure of <130/80 mm Hg, 48.8% achieved a goal low-density lipoprotein cholesterol of <100 mg/dL, and 35.8% had hemoglobin A1c of <7%. Gender comparisons of 2788 diabetic patients at urban and suburban centers showed that women had a lower percentage of low-density lipoprotein cholesterol <100 mg/dL (45.8 vs. 51.3, p<0.01) and a lower percentage of screening for retinopathy (54 vs. 60, p<0.01) and nephropathy (37 vs. 49, p<0.01). However, overall there were no gender differences in the percentage of patients who achieved a goal blood pressure <130/80 mm Hg or hemoglobin A1c <7%. Control of blood pressure and other CVD risk factors in diabetic patients was largely suboptimal, especially for diabetic women. These observations underscore the need for better strategies for control of CVD risk in the diabetic population in general, and women in particular.

Citing Articles

Impact of Guidelines on Hypertension Control in the Elderly.

Rita D, Dobre M, Pagliacci S, Ferri C Curr Pharm Des. 2020; 27(16):1952-1959.

PMID: 33290195 PMC: 9167062. DOI: 10.2174/1381612826666201207230956.


Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial.

Magee M, Tamis-Holland J, Lu J, Bittner V, Brooks M, Lopes N Int J Endocrinol. 2015; 2015:610239.

PMID: 25873955 PMC: 4383496. DOI: 10.1155/2015/610239.


Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study.

Yu M, Lyles C, Bent-Shaw L, Young B Am J Nephrol. 2012; 36(3):245-51.

PMID: 22964976 PMC: 3510352. DOI: 10.1159/000342210.


Hypertension and type 2 diabetes: what family physicians can do to improve control of blood pressure--an observational study.

Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine R, Hall J BMC Fam Pract. 2011; 12:86.

PMID: 21834976 PMC: 3163533. DOI: 10.1186/1471-2296-12-86.


Drug management for hypertension in type 2 diabetes in family practice.

Putnam W, Buhariwalla F, Lacey K, Goodfellow M, Goodine R, Hall J Can Fam Physician. 2009; 55(7):728-34.

PMID: 19602663 PMC: 2718608.


References
1.
Colwell J . Aspirin therapy in diabetes. Diabetes Care. 2002; 26 Suppl 1:S87-8. DOI: 10.2337/diacare.26.2007.s87. View

2.
Grundy S, Benjamin I, Burke G, Chait A, Eckel R, Howard B . Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999; 100(10):1134-46. DOI: 10.1161/01.cir.100.10.1134. View

3.
Turner R, Cull C, Frighi V, Holman R . Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999; 281(21):2005-12. DOI: 10.1001/jama.281.21.2005. View

4.
. American Diabetes Association: clinical practice recommendations 1997. Diabetes Care. 1997; 20 Suppl 1:S1-70. View

5.
Fagard R, Staessen J . Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Clin Exp Hypertens. 1999; 21(5-6):491-7. DOI: 10.3109/10641969909060982. View